Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Fratev

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
ACS Omega|August 29, 2019
Prediction of Accurate Binding Modes Using Combination of Classical and Accelerated Molecular Dynamics and Free-Energy Perturbation Calculations: An Application to Toxicity StudiesFilip Fratev, Thomas Steinbrecher, Svava Ósk Jónsdóttir
Proteins|February 15, 2013
Structural insight into the UNC-45-myosin complexFilip Fratev, Svava Osk Jónsdóttir, Ilza Pajeva
Molecular Pharmaceutics|February 28, 2009
Molecular basis of inactive B-RAF(WT) and B-RAF(V600E) ligand inhibition, selectivity and conformational stability: an in silico studyFilip Fratev, Svava Osk Jónsdóttir, Elina Mihaylova, et al.
International Journal of Molecular Sciences|July 18, 2015
Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent AntagonistsFilip Fratev, Ivanka Tsakovska, Merilin Al Sharif, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of GlyT2 Inhibitors Using Structure-Based Pharmacophore Screening and Selectivity Studies by FEP+ CalculationsFilip Fratev, Manuel Miranda-Arango, Ashley Bryan Lopez, et al.
Journal of Biomolecular Structure & Dynamics|January 15, 2020
Discovery of new AKT1 inhibitors by combination of <i>in silico</i> structure based virtual screening approaches and biological evaluationsFilip Fratev, Denisse A Gutierrez, Renato J Aguilera, et al.
Journal of Agricultural and Food Chemistry|February 16, 2006
QSAR models for Daphnia magna toxicity prediction of benzoxazinone allelochemicals and their transformation productsElena Lo Piparo, Filip Fratev, Frank Lemke, et al.
International Journal of Pharmaceutics|May 11, 2018
Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modelingSaugat Adhikari, Saloni Daftardar, Filip Fratev, et al.
Chemico-Biological Interactions|June 17, 2021
1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studiesKameliya Anichina, Maria Argirova, Rumyana Tzoneva, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Benzimidazoles Containing Piperazine Skeleton at C-2 Position as Promising Tubulin Modulators with Anthelmintic and Antineoplastic ActivityKameliya Anichina, Anelia Mavrova, Dimitar Vuchev, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
ACS Omega|August 29, 2019
Prediction of Accurate Binding Modes Using Combination of Classical and Accelerated Molecular Dynamics and Free-Energy Perturbation Calculations: An Application to Toxicity StudiesFilip Fratev, Thomas Steinbrecher, Svava Ósk Jónsdóttir
Proteins|February 15, 2013
Structural insight into the UNC-45-myosin complexFilip Fratev, Svava Osk Jónsdóttir, Ilza Pajeva
Molecular Pharmaceutics|February 28, 2009
Molecular basis of inactive B-RAF(WT) and B-RAF(V600E) ligand inhibition, selectivity and conformational stability: an in silico studyFilip Fratev, Svava Osk Jónsdóttir, Elina Mihaylova, et al.
International Journal of Molecular Sciences|July 18, 2015
Structural and Dynamical Insight into PPARγ Antagonism: In Silico Study of the Ligand-Receptor Interactions of Non-Covalent AntagonistsFilip Fratev, Ivanka Tsakovska, Merilin Al Sharif, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of GlyT2 Inhibitors Using Structure-Based Pharmacophore Screening and Selectivity Studies by FEP+ CalculationsFilip Fratev, Manuel Miranda-Arango, Ashley Bryan Lopez, et al.
Journal of Biomolecular Structure & Dynamics|January 15, 2020
Discovery of new AKT1 inhibitors by combination of <i>in silico</i> structure based virtual screening approaches and biological evaluationsFilip Fratev, Denisse A Gutierrez, Renato J Aguilera, et al.
Journal of Agricultural and Food Chemistry|February 16, 2006
QSAR models for Daphnia magna toxicity prediction of benzoxazinone allelochemicals and their transformation productsElena Lo Piparo, Filip Fratev, Frank Lemke, et al.
International Journal of Pharmaceutics|May 11, 2018
Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modelingSaugat Adhikari, Saloni Daftardar, Filip Fratev, et al.
Chemico-Biological Interactions|June 17, 2021
1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studiesKameliya Anichina, Maria Argirova, Rumyana Tzoneva, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Benzimidazoles Containing Piperazine Skeleton at C-2 Position as Promising Tubulin Modulators with Anthelmintic and Antineoplastic ActivityKameliya Anichina, Anelia Mavrova, Dimitar Vuchev, et al.
Pageof 3